1. Namkoong, Ho, Edahiro, Ryuya, Takano, Tomomi, Fukunaga, Koichi, Okada, Yukinori. 2022. DOCK2 is involved in the host genetics and biology of severe COVID-19. In Nature, 609, 754-760. doi:10.1038/s41586-022-05163-5. https://pubmed.ncbi.nlm.nih.gov/35940203/
2. Huang, Yushen, Luo, Wen, Chen, Siyun, Shi, Yanxia, Wei, Jinbin. 2022. Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma. In Frontiers in genetics, 13, 872224. doi:10.3389/fgene.2022.872224. https://pubmed.ncbi.nlm.nih.gov/35620462/
3. Ji, Lulin, Xu, Shuquan, Luo, Haiqing, Zeng, Fanwei. 2022. Insights from DOCK2 in cell function and pathophysiology. In Frontiers in molecular biosciences, 9, 997659. doi:10.3389/fmolb.2022.997659. https://pubmed.ncbi.nlm.nih.gov/36250020/
4. Xie, Yuan, Chen, Jun, Wu, Bing, Xie, Lu, Liu, Zhiping. 2021. Dock2 affects the host susceptibility to Citrobacter rodentium infection through regulating gut microbiota. In Gut pathogens, 13, 52. doi:10.1186/s13099-021-00449-x. https://pubmed.ncbi.nlm.nih.gov/34391464/
5. Yang, Hui, Wang, Xinzhi, Blanco-Gómez, Adrián, Perez-Losada, Jesus, Mao, Jian-Hua. 2024. A susceptibility gene signature for ERBB2-driven mammary tumour development and metastasis in collaborative cross mice. In EBioMedicine, 106, 105260. doi:10.1016/j.ebiom.2024.105260. https://pubmed.ncbi.nlm.nih.gov/39067134/
6. Guo, Xia, Li, Feifei, Xu, Zaiyan, Li, Chenxiao, Chen, Shi-You. 2017. DOCK2 deficiency mitigates HFD-induced obesity by reducing adipose tissue inflammation and increasing energy expenditure. In Journal of lipid research, 58, 1777-1784. doi:10.1194/jlr.M073049. https://pubmed.ncbi.nlm.nih.gov/28716822/
智鼠故事 
